Cerus Corporation

NASDAQ:CERS

Medical - Devices

Healthcare
$1.94 +2.92%

+$0.08 today

Market cap
$391.79M
Beta
1.77
P/E (TTM)
-53.8
EPS (TTM)
-$0.05
52W Low $1.15High $3.15

Volume 6.09M

Average 2.33M

CERS Total Assets

Everything the company owns or controls; equal to total liabilities plus equity.

Cerus CorporationNASDAQ: CERS

Total Assets · Q1 FY2026 · quarter ended Mar 2026

Total assets rises 7.8% from a year ago

Total assets stood at $222.91M at the end of Q1 FY2026, up 7.8% from a year earlier and up 0.5% from the prior quarter. Over 3 fiscal years it compounded at +0.6% a year.

Context

  • Total assets increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total assets keeps rising in the next quarterly balance sheet after a +7.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$222.91M+0.5% QoQ
Last fiscal yearDec 2025
$221.86M+10.4% YoY
Year agoMar 2025
$206.78M+7.8% since
Total Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.8%——
1 year+10.4%——
3-year CAGR+0.6%——
5-year CAGR——
10-year CAGR——

Total Assets history

USD · from the balance sheet

Latest · FY2025
221.86M USD
Year-over-year change
+10.4%
4-year CAGR
-1.7%

Total Assets vs competitors

How CERS compares with its peers on the latest reported figures

  • Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +7.8% is the 2nd highest of 4, against a peer median of +1.6%.
  • Over three fiscal years its annual growth of +0.6% compares with a peer median of +7.4%.
CERS Competitors
Total Assets for CERS and competitors
Company Period Latest balance YoY 3-year CAGR
GRFSGrifols, S.A.Jun 2026€20.09B EUR+1.6%-2.4%
HAEHaemonetics CorporationJun 2026$2.37B USD-3.9%+7.4%
ADMAADMA Biologics, Inc.Jun 2026$684.21M USD+22.5%+21.5%
CERSCerus CorporationMar 2026$222.91M USD+7.8%+0.6%
Peer median (excluding CERS) —+1.6%+7.4%

Competitors are the stored peer set for CERS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents48.76M35.59M11.65M20.27M19.96M
Short-term Investments80.6M66.57M54.21M60.19M62.92M
Net Receivables25.13M34.43M35.5M29.78M30.37M
Inventory26.79M29M39.87M38.15M56.1M
Other Current Assets04.56M3.22M3.64M5.03M
Total Current Assets187.1M170.14M144.44M152.02M174.38M
Property, Plant & Equipment (Net)25.18M23.48M19.35M15.54M19.33M
Goodwill1.32M1.32M1.32M1.32M1.32M
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets23.9M23.15M32.64M32.04M26.83M
Total Non-current Assets50.4M47.95M53.31M48.9M47.48M
Total Assets237.5M218.09M197.75M200.92M221.86M
Account Payables35.61M33M23.84M21.7M28.01M
Short-term Debt14.7M56.16M20M19.3M43.34M
Tax Payables00000
Deferred Revenue673K589K2M1.4M1.27M
Other Current Liabilities18.51M17.58M11.82M11.94M18.26M
Total Current Liabilities78.56M117.06M67.52M63.61M100.8M
Long-term Debt54.72M13.64M59.8M64.86M40.55M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.34M3.5M3.24M3.89M5.4M
Total Non-current Liabilities73.33M32.47M76.78M80.41M56.09M
Total Liabilities151.88M149.53M144.3M144.02M156.89M
Common Stock174K177K181K186K192K
Retained Earnings(964.34M)(1.01B)(1.04B)(1.07B)(1.08B)
Accumulated OCI(149K)(2.79M)(1.27M)(400K)(156K)
Other Stockholders Equity00000
Minority Interest998K952K794K751K741K
Total Equity85.62M68.56M53.44M56.9M64.97M
Total Debt87.59M87.24M96M98.1M96.95M
Net Debt38.83M51.65M84.35M77.83M76.99M

Cerus Corporation

NASDAQ:CERS

Intrinsic Alpha fair value

Locked

Current Price

$1.94

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.